Pre-exposure prophylaxis (PrEP) consists in the use of an antiretroviral medication to prevent the acquisition of HIV infection by uninfected individuals and has recently demonstrated to be highly efficacious for HIV prevention. We propose a new epidemiological model for HIV/AIDS transmission including PrEP. Existence, uniqueness and global stability of the disease free and endemic equilibriums are proved. The model with no PrEP is calibrated with the cumulative cases of infection by HIV and AIDS reported in Cape Verde from 1987 to 2014, showing that it predicts well such reality. An optimal control problem with a mixed state control constraint is then proposed and analyzed, where the control function represents the PrEP strategy a...
Graduation date: 2016Apart from the traditional role of preventing progression from HIV to AIDS, ant...
The potential for emergence and spread of HIV drug resistance from rollout of antiretroviral (ARV) p...
Background: Preexposure prophylaxis (PrEP) with tenofovir and emtricitabine can prevent new HIV-1 in...
Abstract Antiretroviral treatment (ART) and oral pre-exposure prophylaxis (PrEP) have recently been ...
Prevention of type-1 human immunodeficiency virus (HIV) infections has primarily been through condom...
Mathematical modelers have given little attention to the question of how pre-exposure prophylaxis (P...
The human immunodeficiency virus (HIV) impairs a person\u27s immune system against many infections a...
Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infect...
Preexposure prophylaxis (PrEP) is a promising intervention to help end the HIV epidemic among men wh...
Objectives: HIV pre-exposure prophylaxis (PrEP) may change serosorting patterns. We examined the inf...
In this paper, we developed HIV/AIDS mathematical model which comprises important compartments such ...
Pre-exposure prophylaxis (PrEP) is a promising new HIV prevention method, especially for women. An u...
BACKGROUND: The potential for emergence and spread of HIV drug resistance from rollout of antiretrov...
Introduction: The new WHO guidelines recommend offering pre-exposure prophylaxis (PrEP) to people wh...
ObjectivesIdentifying prescribing strategies that improve the efficiency of PrEP should increase its...
Graduation date: 2016Apart from the traditional role of preventing progression from HIV to AIDS, ant...
The potential for emergence and spread of HIV drug resistance from rollout of antiretroviral (ARV) p...
Background: Preexposure prophylaxis (PrEP) with tenofovir and emtricitabine can prevent new HIV-1 in...
Abstract Antiretroviral treatment (ART) and oral pre-exposure prophylaxis (PrEP) have recently been ...
Prevention of type-1 human immunodeficiency virus (HIV) infections has primarily been through condom...
Mathematical modelers have given little attention to the question of how pre-exposure prophylaxis (P...
The human immunodeficiency virus (HIV) impairs a person\u27s immune system against many infections a...
Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infect...
Preexposure prophylaxis (PrEP) is a promising intervention to help end the HIV epidemic among men wh...
Objectives: HIV pre-exposure prophylaxis (PrEP) may change serosorting patterns. We examined the inf...
In this paper, we developed HIV/AIDS mathematical model which comprises important compartments such ...
Pre-exposure prophylaxis (PrEP) is a promising new HIV prevention method, especially for women. An u...
BACKGROUND: The potential for emergence and spread of HIV drug resistance from rollout of antiretrov...
Introduction: The new WHO guidelines recommend offering pre-exposure prophylaxis (PrEP) to people wh...
ObjectivesIdentifying prescribing strategies that improve the efficiency of PrEP should increase its...
Graduation date: 2016Apart from the traditional role of preventing progression from HIV to AIDS, ant...
The potential for emergence and spread of HIV drug resistance from rollout of antiretroviral (ARV) p...
Background: Preexposure prophylaxis (PrEP) with tenofovir and emtricitabine can prevent new HIV-1 in...